1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Multivariable logistic regression analysis
Outcome: Major Complications OR (Statin vs No Statin) 95% Lower Bound 95% Upper Bound P Value All-cause mortality 0.72 0.34 1.53 .397 Major ipsilateral intracranial hemorrhage 0.31 0.09 1.14 .078 Major ipsilateral ischemic stroke 1.43 0.66 3.09 .362 Major morbidity 0.83 0.42 1.64 .593 Major morbidity and neurologic mortality 0.80 0.44 1.47 .478 Neurologic mortality 0.65 0.28 1.47 .298 Stenosis >50% at last follow-up 2.83 0.53 15.09 .224 Without complete aneurysm occlusion at last follow-up 1.20 0.54 2.66 .657